Larvol Delta - Coya-Therapeutics-to-Present-ProofofConcept-Clinical-Data-for-LowDose-Interleukin2-ld-IL2-for-the-Treatment-of-Patients-with-Alzheimers-Disease-AD-at-the-2023-Alzheimers-Association-International-Conference-AAIC

COYA 301 - Coya Therap

https://www.businesswire.com/news/home/20230628076008/en/Coya-Therapeutics-to-Present-Proof-of-Concept-Clinical-Data-for-Low-Dose-Interleukin-2-ld-IL-2-for-the-Treatment-of-Patients-with-Alzheimer%E2%80%99s-Disease-AD-at-the-2023-Alzheimer%E2%80%99s-Association-International-Conference-AAIC

Jun 28, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next